NLS PHARMACEUTICS LTD (NLSP) Stock Earnings & Estimates
NASDAQ:NLSP - CH1384053976 - Common Stock
2.198 USD
-0.02 (-0.99%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | |||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | -11.85M | -15.47M -30.55% | -11.796M 23.75% | -3.633M 69.20% | N/A | |
| EBIT YoY % growth | -5.77M | -3.45M 40.21% | -4.2M -21.74% | -2.3M 45.24% | -11.86M -415.65% | -15.48M -30.52% | -11.807M 23.73% | -3.636M 69.20% | N/A -649.06% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A -5.88% | N/A -1.24% | N/A 30.49% | N/A 89.47% | N/A 71.88% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |